Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Bone Biologics (BBLGW) EBT Margin (2016 - 2017)

Bone Biologics (BBLGW) has disclosed EBT Margin for 2 consecutive years, with 189.83% as the latest value for Q4 2017.

  • Quarterly EBT Margin changed N/A to 189.83% in Q4 2017 from the year-ago period, while the trailing twelve-month figure was 159.38% through Dec 2017, down 234764.0% year-over-year, with the annual reading at 2471.56% for FY2025, 142900.0% up from the prior year.
  • EBT Margin for Q4 2017 was 189.83% at Bone Biologics, down from 190.83% in the prior quarter.
  • The five-year high for EBT Margin was 3954.41% in Q1 2016, with the low at 106.36% in Q2 2017.